Search research articles
Contact Us
Filters
Showing results (71-80 of 81) with videos related to
Page
of 9
Sort By:
Multiple Sclerosis and Related Disorders
|
March 12, 2017
Is multiple sclerosis a length-dependent central axonopathy? The case for therapeutic lag and the asynchronous progressive MS hypotheses
Gavin Giovannoni, Gary Cutter, Maria Pia Sormani, et al.
The New England Journal of Medicine
|
December 22, 2016
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
Stephen L Hauser, Amit Bar-Or, Giancarlo Comi, et al.
Journal of Neuromuscular Diseases
|
July 12, 2024
Smartphone-Based Assessment of Mobility and Manual Dexterity in Adult People with Spinal Muscular Atrophy
Eduardo Arteaga-Bracho, Gautier Cosne, Christoph Kanzler, et al.
JAMA Network Open
|
February 12, 2024
Artificial Intelligence Assistive Software Tool for Automated Detection and Quantification of Amyloid-Related Imaging Abnormalities
Diana M Sima, Thanh Vân Phan, Simon Van Eyndhoven, et al.
The New England Journal of Medicine
|
December 22, 2016
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
Xavier Montalban, Stephen L Hauser, Ludwig Kappos, et al.
Clinical Neurology and Neurosurgery
|
December 11, 2012
Phenotypical characterization of α-galactosidase A gene mutations identified in a large Fabry disease screening program in stroke in the young
Isabel De Brabander, Laetitia Yperzeele, Chantal Ceuterick-De Groote, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
December 27, 2025
Safety and efficacy of opicinumab in participants with relapsing multiple sclerosis (AFFINITY Part 1): A randomized, controlled, phase 2 trial
Peter A Calabresi, Gavin Giovannoni, Hans-Peter Hartung, et al.
JMIR Formative Research
|
November 8, 2024
Sensor-Derived Measures of Motor and Cognitive Functions in People With Multiple Sclerosis Using Unsupervised Smartphone-Based Assessments: Proof-of-Concept Study
Matthew Scaramozza, Aurélie Ruet, Patrizia A Chiesa, et al.
Neurology. Clinical Practice
|
April 23, 2016
Comparative efficacy of first-line natalizumab vs IFN-β or glatiramer acetate in relapsing MS
Tim Spelman, Tomas Kalincik, Vilija Jokubaitis, et al.
Nature Medicine
|
March 4, 2025
Smartwatch- and smartphone-based remote assessment of brain health and detection of mild cognitive impairment
Paul Monroe Butler, Jenny Yang, Roland Brown, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 81) with videos related to
Sort By:
Page
of 9
Multiple Sclerosis and Related Disorders
|
March 12, 2017
Is multiple sclerosis a length-dependent central axonopathy? The case for therapeutic lag and the asynchronous progressive MS hypotheses
Gavin Giovannoni, Gary Cutter, Maria Pia Sormani, et al.
The New England Journal of Medicine
|
December 22, 2016
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
Stephen L Hauser, Amit Bar-Or, Giancarlo Comi, et al.
Journal of Neuromuscular Diseases
|
July 12, 2024
Smartphone-Based Assessment of Mobility and Manual Dexterity in Adult People with Spinal Muscular Atrophy
Eduardo Arteaga-Bracho, Gautier Cosne, Christoph Kanzler, et al.
JAMA Network Open
|
February 12, 2024
Artificial Intelligence Assistive Software Tool for Automated Detection and Quantification of Amyloid-Related Imaging Abnormalities
Diana M Sima, Thanh Vân Phan, Simon Van Eyndhoven, et al.
The New England Journal of Medicine
|
December 22, 2016
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
Xavier Montalban, Stephen L Hauser, Ludwig Kappos, et al.
Clinical Neurology and Neurosurgery
|
December 11, 2012
Phenotypical characterization of α-galactosidase A gene mutations identified in a large Fabry disease screening program in stroke in the young
Isabel De Brabander, Laetitia Yperzeele, Chantal Ceuterick-De Groote, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
December 27, 2025
Safety and efficacy of opicinumab in participants with relapsing multiple sclerosis (AFFINITY Part 1): A randomized, controlled, phase 2 trial
Peter A Calabresi, Gavin Giovannoni, Hans-Peter Hartung, et al.
JMIR Formative Research
|
November 8, 2024
Sensor-Derived Measures of Motor and Cognitive Functions in People With Multiple Sclerosis Using Unsupervised Smartphone-Based Assessments: Proof-of-Concept Study
Matthew Scaramozza, Aurélie Ruet, Patrizia A Chiesa, et al.
Neurology. Clinical Practice
|
April 23, 2016
Comparative efficacy of first-line natalizumab vs IFN-β or glatiramer acetate in relapsing MS
Tim Spelman, Tomas Kalincik, Vilija Jokubaitis, et al.
Nature Medicine
|
March 4, 2025
Smartwatch- and smartphone-based remote assessment of brain health and detection of mild cognitive impairment
Paul Monroe Butler, Jenny Yang, Roland Brown, et al.
Page
of 9